Study of stool bacteria transplant to help people with infections
Part of Digestive system clinical trials.
This study looks at fecal microbiota transplantation (FMT), which is a stool bacteria transplant, to help adults whose symptoms persist or return, often from C. difficile infection. If you’re already planning or receiving FMT for certain conditions, this trial may add information on how it helps and who benefits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years
- Be receiving FMT for C. difficile infection (rCDI) or another medical condition
- Be able to give written consent (sign forms)
- Not be enrolled in any other FMT (stool transplant) trial at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a stool transplant (also called FMT) can treat a new, early C. difficile infection in people who have improved while on antibiotics. It may help some people prevent the infection from coming back or worsening.
This trial studies whether fecal microbiota transplantation (a procedure that transfers healthy stool bacteria) can change a person’s gut bacteria after repeated C. difficile infection. It may help reduce recurring infections by restoring a healthier balance of gut microbes.
This trial studies using a fecal microbiota transplant (FMT)—healthy gut bacteria moved from a screened donor—to help treat recurring or hard-to-control C. difficile infection. It may help restore a healthier gut environment when standard treatments keep failing or the infection returns.
This study uses fecal microbiota transplantation (FMT) — transferring gut bacteria from a healthy donor — to see how it affects the gut microbiome in people with ulcerative colitis, metabolic syndrome, or recurrent C. difficile infection. It may help stabilize the gut bacteria and improve symptoms.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This study tests a stool-based treatment (fecal microbiota treatment) to help remove “carbapenem-resistant” bacteria living in the gut. If you carry these bacteria without being sick, the goal is to reduce or stop that colonization.
Hear when a new Faecal Microbiota Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.